Lunai Bioworks Inc. provides AI platforms for ADI's defense work, with David Weinstein serving as CEO.
3 reports, 1 independent
Updated Sep 4
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lunai Bioworks Inc. provides AI platforms for ADI's defense work, with David Weinstein serving as CEO.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
David Weinstein
American musician
Nothing else this week.
-
ADI
Nothing else this week.
Coverage
Newest first; wire copies grouped- ACCESS NewswireLunai Bioworks Inc. Retains American Defense International Collaboration aims to apply Lunai Bioworks Inc. biomedical AI platform to accelerate countermeasure development for chemical agents like sar
- ACCESS NewswireRenovaro Inc. (NASDAQ: RENB) Mentioned in RealClearDefense Article on AI and Biodefense Risks LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 8, 2025 / Renovaro Inc. (NASDAQ:RENB) was referenced i
- ACCESS NewswirePeer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy Landmark preclinical data validate Renovaro's platform representing a step forwa